Press Releases and Statements

Statement on Biden Executive Order Regarding OTC Hearing Aids from Peter Borsuk, Chair of CHPA’s Consumer Medical Devices Council, and President & CEO of Lansinoh Laboratories.

CHPA applauds FDA's inclusion of the publication of a revised version of the New Dietary Ingredient (NDI) Draft Guidance within its priorities for 2022.

Ohio Governor Mike DeWine signed into law HB 9, prohibiting the sale of DXM-containing products to minors.

CHPA awarded its Ivan D. Combe Lifetime Achievement Award Wednesday to longtime industry leader Scott Emerson.

Oregon has repealed a 15-year-old law that banned OTC sales of certain medicines for colds and allergies containing PSE.

The Consumer Healthcare Products Association (CHPA) today announced the election of Michelle Wang Goodridge as the new Chair of the CHPA Board of Directors. Goodridge was elected along with six new board members.

CHPA commends Senators Wyden, Paul, and Merkley for their bipartisan bill which will provide a pathway for CBD to be legally marketed as a dietary supplement.

In a new letter, ACI and CHPA call on FDA to withdraw its temporary guidance for the manufacturing of alcohol-based hand sanitizer products.

The American Herbal Products Association (AHPA), the Consumer Healthcare Products Association (CHPA), the Council for Responsible Nutrition (CRN), and the United Natural Products Alliance (UNPA) commemorate the 100th meeting of the Dietary Supplement Trade Associations (DSTA).

The Consumer Healthcare Products Association (CHPA) released a statement commending the House of Representatives following its passage of H.R. 1996, the SAFE Banking Act.

CHPA congratulates Patrizia Cavazzoni on her recent appointment as director of FDA’s Center for Drug Evaluation and Research (CDER).

CHPA applauds FDA’s recent emergency use authorization for a number of over-the-counter (OTC) nonprescription self-testing products for COVID-19.